Global market for the display of biological data (2021 to 2026): by technique, application, platform, end use and geography –

DOUBLE – (BUSINESS WIRE) – The report “Global market for visualization of biological data (2021-2026) by technique, application, platform, end use, geography, competitive analysis and the impact of COVID-19 with Ansoff analysis has been added” offering.

The global market for biological data visualization is estimated to be $ 880 million in 2021 and is expected to reach € 1,360.2 million in 2026, growing at a CAGR of 9.1%.

Key factors, such as raising awareness among physicians and patients about the benefits of visualizing biological data, will help drive market growth. Also the prevalence of biological data, the adoption of artificial intelligence for the analysis of biological data, the growing need for faster decision making are some of the factors that are likely to drive market growth. On the other hand, the introduction of a virtual reality environment and advanced analytical tools that will further enhance various opportunities that will lead to market growth.

Problems related to the user interface along with the unavailability of computational consistency for data management, which are likely to hinder the growth of the biological data visualization market.

Market segmentation

The global biological data visualization market is more segmented based on technique, application, platform, end use, and geography.

  • By techniques, the market is classified as microscopy, MRI, imaging, sequencing, X-ray crystallography and others. Among them, it is estimated that the microscopy segment has the highest market share.

  • By application, the market is classified as image by cells and organisms, structural biology and molecular modeling, genomics analysis, alignments, phylogeny and evolution and systems biology. Among them, it is estimated that Genomics Analysis will maintain the highest market share during the forecast period.

  • By platforms, the market is classified as Windows, Mac OS, Linux and others. Among them, the Windows segment has the highest market share.

  • For end use, the market is classified as academic research, hospitals and clinics, pharmaceutical and biotechnology companies and others. Among them, it is estimated that academic research has the highest market share.

  • For Geography, North America is expected to lead the market.

Recent developments

1. Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, has announced the release of Genedata Imagence 3.0, the latest version of deep learning-based software that automates image data analysis high content screening (HCS). – January 19, 2021

2. Thermo Fisher Scientific has announced the completion of the acquisition of Phitonex, Inc., a Durham, North Carolina-based company that has pioneered a spectral dyeing platform for high-resolution biology applications designed to Accelerate Research and Development in Cell Therapy, -Oncology and Immunology Research – December 31, 2020

Why buy this report?

  • The report provides a comprehensive assessment of the global biological data visualization market.

  • The report includes in-depth qualitative analysis, verifiable data from authentic sources and market size projections. Projections are calculated using proven research methodologies.

  • The report has been compiled through extensive primary and secondary research. The main research is conducted through interviews, surveys and observations of recognized industry personnel.

  • The report includes a detailed market analysis using Porter’s 5-force model and the Ansoff matrix. The impact of COVID-19 on the market is also shown in the report.

  • The report also contains the competitive analysis using Competitive Quadrant, the analyst’s proprietary competitive positioning tool.

Highlights of the report:

  • A complete analysis of the market, including the parent industry

  • Important market dynamics and trends

  • Market segmentation

  • Historical, current and projected size of the market according to value and volume

  • Market shares and key player strategies

  • Recommendations to companies to strengthen their position in the market

Market dynamics


  • Rapid growth of biological data

  • Incorporation of artificial intelligence in the analysis of biological data

  • Growing demand for faster decision making

  • Increased awareness among doctors and patients


  • User interface challenges related to data visualization

  • Lack of computational consistency for data management


  • Introduction to the virtual reality environment

  • Advanced analytical tools


  • Increasing integration of AI and IoT in the handling of biological data

Mentioned companies

  • 3M Co.

  • Agilent Technologies Inc.

  • ariva AG

  • Becton, Dickinson and Co.

  • Bruker Corp.

  • Clarivar Analytics

  • Carl Zeiss AG

  • Danaher Corp.

  • Fios Genomics

  • Boon Inc.

  • Genedata AG

  • Media Cybernetics INC

  • Molecular Devices, LLC

  • Nikon Corp.

  • Oxford Instruments

  • Olympus Corp.

  • Scientific Volume Imaging BV

  • Thermo Fisher Scientific Inc.

  • TIBCO Software Inc.


For more information on this report, visit

Source link

Leave a Comment

Your email address will not be published.